Assess your colorectal cancer risk based on age, family history, lifestyle factors, and comorbidities. Get personalized screening recommendations.
The Colorectal Cancer (CRC) Screening Risk Calculator estimates your 10-year and lifetime risk of developing colorectal cancer based on established risk factors, and provides personalized screening recommendations aligned with current USPSTF, ACS, and ACG guidelines. Colorectal cancer is the third most common cancer and second leading cause of cancer death in the United States, with approximately 153,000 new cases and 53,000 deaths annually.
The good news: CRC is one of the most preventable cancers through screening. Colonoscopy detects and removes precancerous polyps before they become malignant, and regular FIT testing catches early-stage cancers when 5-year survival exceeds 90%. In 2021, the USPSTF lowered the recommended screening age from 50 to 45 based on rising CRC rates in younger adults.
This calculator evaluates your age, sex, race/ethnicity, family history, medical history (IBD, polyps, diabetes), and lifestyle factors (smoking, alcohol, diet, physical activity, obesity) to generate a risk profile. Based on your risk level, it recommends specific screening tests and intervals, including colonoscopy, FIT, Cologuard, CT colonography, and flexible sigmoidoscopy.
Many adults delay CRC screening because they don't understand their personal risk level. This calculator quantifies your risk and explains which screening test is most appropriate, helping you have an informed conversation with your doctor. Early detection through screening reduces CRC mortality by 40–60%. Keep these notes focused on your operational context.
Base 10-year Risk by Age: <40: 0.1%, 40s: 0.4%, 50s: 0.9%, 60s: 1.5%, 70s: 2.0%, 80+: 2.5% Risk Multiplier = 1 + (Total Risk Points × 0.3) Adjusted Risk = Base Risk × Risk Multiplier × Sex Factor × Race Factor Risk Points: Family history (2), Polyps (2), IBD (3), Smoking (1), Alcohol (1), Obesity (1), Inactivity (1), Processed meat (1), Diabetes (1)
Result: 10-Year Risk: 1.66% — Moderate Risk
At age 55, male, base 10-year risk is 0.9%. Male adjustment increases to ~1.04%. Family history (2 points) + obesity (1 point) = 3 points. Risk multiplier = 1 + 3 × 0.3 = 1.9. Adjusted risk = 1.04% × 1.9 = 1.97%. This moderate-risk profile warrants colonoscopy every 5 years starting at age 40.
CRC incidence has been declining overall since the mid-1980s, largely due to increased screening and polyp removal. However, rates in adults under 50 have been rising by ~2% per year since the mid-1990s, prompting the lowering of recommended screening age to 45. CRC remains more common in men than women (1.2:1) and disproportionately affects Black Americans, who have 20% higher incidence and mortality rates.
Colonoscopy offers the highest single-test sensitivity (95%) and the ability to both detect and remove precancerous polyps in one procedure. FIT is non-invasive, inexpensive, and requires no bowel prep or sedation, making it more accessible. CT colonography provides a structural view without sedation but cannot remove polyps. Cologuard combines DNA and hemoglobin testing for higher sensitivity than FIT alone. The best test is the one that gets done — all options reduce CRC mortality.
Multiple modifiable factors contribute to CRC risk: physical inactivity (30% increased risk), obesity (20% increased risk), heavy alcohol use (50% increased risk for >3 drinks/day), smoking (18% increased risk), and high red/processed meat consumption (17% increased risk per 100g/day). Addressing these factors alongside screening provides the most comprehensive CRC prevention strategy.
The USPSTF and ACS recommend screening at age 45 for average-risk adults. If you have a family history of CRC (especially first-degree relative diagnosed before 60), IBD, Lynch syndrome, or familial adenomatous polyposis, screening should begin at 25–40 depending on the specific condition.
When done annually, FIT testing provides comparable cancer detection to colonoscopy over time. FIT detects ~74% of cancers with each test, and annual testing catches most cancers over sequential rounds. The key is adherence — FIT must be done every year. Colonoscopy provides one-time 95% sensitivity and can remove precancerous polyps during the procedure.
Warning signs include blood in stool, persistent change in bowel habits, unexplained weight loss, abdominal cramping, and iron-deficiency anemia. However, early CRC is usually asymptomatic — that's why screening is essential. Don't wait for symptoms to get screened.
Yes. One first-degree relative with CRC doubles your risk; two first-degree relatives increases it 3–4×. If the relative was diagnosed before age 50, your risk increases further. Lynch syndrome (hereditary nonpolyposis CRC) and FAP carry lifetime CRC risks of 50–80% and nearly 100%, respectively.
Cologuard (multi-target stool DNA test, mt-sDNA) is a home stool test that detects both DNA mutations and blood associated with CRC. It has ~92% sensitivity for cancer but a higher false-positive rate (~13%) than FIT. Recommended every 3 years. A positive Cologuard always requires follow-up colonoscopy.
Evidence strongly supports that a diet high in fiber, fruits, vegetables, and whole grains while low in red and processed meat reduces CRC risk by 20–35%. Calcium and vitamin D supplementation may also be protective. The Mediterranean diet pattern is associated with the lowest CRC incidence.